Murray Christine

Insider profile

Performance

Overall performance
2.2

Performance over holding periods
2.2
30 days 90 days 120 days
Average return -35% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Murray Christine's trades of Eiger BioPharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2023-01-03 2022-12-29 S Sale
72,601 -25.3%
470.52
US$2,224,789
72,601 -25.3% 470.52 US$2,224,789